HEPATIC CANCER AND ITS RISK FACTORS IN NOVOSIBIRSK
https://doi.org/10.21294/1814-4861-2016-15-3-19-27
Abstract
The dynamics of morbidity and mortality due to primary liver cancer in the population of Novosibirsk according to population cancer register and the total mortality over 25 years (1988-2012) as well as the levels of its risk factors were analyzed. There was a 2-2.5-fold reduction in morbidity and mortality from liver cancer. Among the risk factors, a significant reduction in the incidence of hepatitis B and increase in the incidence of hepatitis C were noted. Prevalence of metabolic syndrome, opisthorchiasis and alcohol consumption remain stable. The epidemiological prognosis for liver cancer in the coming years in the region is discussed.
About the Authors
O. V. Reshetnikov
Research Institute of Internal and Preventive Medicine, Novosibirsk
Russian Federation
MD, DSc, Leading Researcher, Gastroenterology Laboratory
Russian Federation
MD, DSc, Leading Researcher, Gastroenterology Laboratory
T. G. Openko
Research Institute of Internal and Preventive Medicine, Novosibirsk, Novosibirsk State Pedagogical University, Novosibirsk
Russian Federation
MD, Researcher, Gastroenterology Laboratory
Russian Federation
MD, Researcher, Gastroenterology Laboratory
S. A. Kurilovich
Research Institute of Internal and Preventive Medicine, Novosibirsk, Novosibirsk State Medical University, Novosibirsk
Russian Federation
MD, DSc, Professor, Head of Gastroenterology Laboratory
Russian Federation
MD, DSc, Professor, Head of Gastroenterology Laboratory
A. A. Khryanin
Novosibirsk State Medical University, Novosibirsk
Russian Federation
MD, DSc, Professor
Russian Federation
MD, DSc, Professor
S. K. Malyutina
Research Institute of Internal and Preventive Medicine, Novosibirsk, Novosibirsk State Medical University, Novosibirsk
Russian Federation
MD, DSc, Professor
Russian Federation
MD, DSc, Professor
References
1. Bogdanov A.O., Prokudina D.V., Baykov A.N., Saltykova I.V. Molecular mechanisms that lead to Cholangiocarcinoma, during chronic infection of liver flukes // Sibirskiy onkologicheskiy zhurnal. 2015. № 6. P. 83–90. [in Russian]
2. Malignancies in Russia in 2010 (morbidity and mortality) / Ed. V.I. Chissov, V.V. Starinskiy, G.V. Petrova. M., 2012. 260 p. [in Russian]
3. Kylbanova E.S., Maliutina S.K., Nasonova N.V., Nikitin Iu.P. 10-year trends in body weight in men and women in Novosibirsk (1985–1995) // Terapevticheskyi Arkhiv. 2005. Vol. 77 (3). P. 64–67. [in Russian]
4. Merabishvili V.M., Merabishvili E.N., Chepik O.F. Hepatic cancer epidemiology. Incidence, mortality, dynamics of histological structure //Sibirskiy onkologicheskiy zhurnal. 2015. № 2. P. 5–14. [in Russian]
5. Nemtsov A.V., Shelygin K.V. Alcohol consumption in Russia: 1956–2012 // Voprosy narkologii. 2014. № 5. P. 3–12. [in Russian]
6. Yunusova N.V., Kondakova I.V., Kolomiets L.A., Afanasiev S.G., Chernyshova A.L., Shatokhina O.V., Frolova A.E., Zhiwei Zhou, Wei Wang. Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor invasion and metastasis // Voprosy onkologii. 2015/ Vol. 61 (4). P. 619–623. [in Russian]
7. Yasyukevich N.V., Ryabikov A.N., Shakhmatov S.G., Kurilovich S.A., Reshetnikov O.V., Malyutina S.K. Fatty liver disease by ultrasound: prevalence and associations with cardiometabolic risk factors in a Siberian population // Ateroscleroz. 2015. Vol. 11 (1). Р. 27–33. [in Russian]
8. Bobak M., Room R., Pikhart H., Kubinova R., Malyutina S., Pajak A., Kurilovitch S., Topor R., Nikitin Yu., Marmot M. Contribution of drinking patterns to differences in rates of alcohol related problems between three urban populations // J. Epidemiol. Community Health. 2004. Vol. 58. P. 238–242. doi: 10.1136/jech.2003.011825.
9. Bosch F.X., Ribes J., Díaz M., Cléries R. Primary liver cancer: worldwide incidence and trends // Gastroenterology. 2004. Vol. 127 (5 Suppl 1). S5–S16.
10. Bosetti C., Turati F., La Vecchia C. Hepatocellular carcinoma epidemiology // Best Pract. Res. Clin. Gastroenterol. 2014. Vol. 28 (5). P. 753–770. doi: 10.1016/j.bpg.2014.08.007.
11. Corrao G., Bagnardi V., Zambon A., La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases // Prev. Med. 2004. Vol. 38 (5). P. 613–619.
12. El-Serag H.B., Tran T., Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma // Gastroenterology. 2004. Vol. 126 (2). P. 460–468.
13. El-Serag H.B. Hepatocellular carcinoma // N. Engl. J. Med. 2011. Vol. 365. P. 1118–1127. doi: 10.1056/NEJMra1001683.
14. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int. J. Cancer. 2010. Vol. 127. P. 2893–2917. doi: 10.1002/ijc.25516.
15. Freeman A., Dore G., Law M., Thorpe M., Von Overbeck J., Lloyd A.R., Marinos G., Kaldor J.M. Estimating progression to cirrhosis in chronic hepatitis C virus infection // Hepatology. 2001. Vol. 34 (4 Pt 1). P. 809–816.
16. International Agency for Research on Cancer. Consumption of alcoholic beverages // IARC Monographs on The Evaluation of Carcinogenic Risks to Humans. Lyon, France. 2012. Vol. 100E. P. 373–472. URL: http://monographs.iarc.fr/ENG/Monographs/vol100E/mono100E.pdf.
17. Lafaro K.J., Demirjian A.N., Pawlik T.M. Epidemiology of hepatocellular carcinoma // Surg. Oncol. Clin. N. Am. 2015. Vol. 24 (1). P. 1–17. doi: 10.1016/j.soc.2014.09.001.
18. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment // Environ Health Perspect. 2010. Vol. 118 (6). P. 818–824. doi: 10.1289/ehp.0901388.
19. Lvova M.N., Tangkawattana S., Balthaisong S., Katokhin A.V., Mordvinov V.A., Sripa B. Comparative histopathology of Opisthorchis felineus and Opisthorchis viverrini in a hamster model: an implication of high pathogenicity of the European liver fluke // Parasitol. Int. 2012. Vol. 61 (1). P. 167–172. doi: 10.1016/j.parint.2011.08.005.
20. Malek N.P., Schmidt S., Huber P., Manns M.P., Greten T.F. The diagnosis and treatment of hepatocellular carcinoma // Dtsch. Arztebl. Int. 2014. Vol. 111 (7). P. 101–116. doi: 10.3238/arztebl.2014.0101.
21. Malyutina S.K., Bobak M., Kurilovitch S., Ryzova E., Nikitin Yu.P., Marmot M. Alcohol consumption and binge drinking in Novosibirsk, 1985–1995 // Addiction. 2001. Vol. 96 (7). P. 987–995.
22. Siegel A.B., Zhu A.X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link // Cancer. 2009. Vol. 115 (24). P. 5651–5661. doi: 10.1002/cncr.24687.
23. Starley B.Q., Calcagno C.J., Harrison S.A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection // Hepatology. 2010. Vol. 51 (5). P. 1820–1832. doi: 10.1002/hep.23594.
24. Wu C.Y., Hsu Y.C., Ho H.J., Chen Y.J., Lee T.Y., Lin J.T. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study // Gut. 2016. Vol. 65 (4). P. 693–701. doi: 10.1136/gutjnl-2014-308786.
25.
26.
Review
For citations:
Reshetnikov O.V., Openko T.G., Kurilovich S.A., Khryanin A.A., Malyutina S.K. HEPATIC CANCER AND ITS RISK FACTORS IN NOVOSIBIRSK. Siberian journal of oncology. 2016;15(3):19-27. (In Russ.) https://doi.org/10.21294/1814-4861-2016-15-3-19-27
Views:
937
Email this article 
